---
figid: PMC11791101__41420_2025_2327_Fig1_HTML
figtitle: Normal activation mechanism of hedgehog signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11791101
filename: 41420_2025_2327_Fig1_HTML.jpg
figlink: /pmc/articles/PMC11791101/figure/F1/
number: F1
caption: 'A Without HH ligand activation: Ptch1 inhibits Smo, preventing it from translocating
  to the cilium. SuFu binds with Gli2/3 and moves into the cilium, where Gli2/3 is
  phosphorylated by CK1, PKA, and GSK3β, causing Gli2/3 to separate from SuFu. Gli2
  and Gli3 then cross the nuclear membrane into the nucleus, where they repress the
  transcription of target genes, with Gli3 being the primary repressor. B With HH
  ligand activation: The HH secreting cell releases the HH ligand, activating Smo
  and causing it to translocate to the cilium. SuFu binds with Gli2/3 and moves into
  the cilium, where Gli2/3 is phosphorylated by EVC and EVC2, causing Gli2/3 to separate
  from SuFu. Gli3 remains in the cytoplasm, while Gli2 crosses the nuclear membrane
  into the nucleus, where it initiates the transcription of target genes. Created
  with BioRender.com'
papertitle: Mechanisms and therapeutic potential of the hedgehog signaling pathway
  in cancer
reftext: Ge Cong, et al. Cell Death Discov. 2025;11(NA).
year: '2025'
doi: 10.1038/s41420-025-02327-w
journal_title: Cell Death Discovery
journal_nlm_ta: Cell Death Discov
publisher_name: Nature Publishing Group
keywords: Gastric cancer | Gastric cancer
automl_pathway: 0.9579681
figid_alias: PMC11791101__F1
figtype: Figure
redirect_from: /figures/PMC11791101__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11791101__41420_2025_2327_Fig1_HTML.html
  '@type': Dataset
  description: 'A Without HH ligand activation: Ptch1 inhibits Smo, preventing it
    from translocating to the cilium. SuFu binds with Gli2/3 and moves into the cilium,
    where Gli2/3 is phosphorylated by CK1, PKA, and GSK3β, causing Gli2/3 to separate
    from SuFu. Gli2 and Gli3 then cross the nuclear membrane into the nucleus, where
    they repress the transcription of target genes, with Gli3 being the primary repressor.
    B With HH ligand activation: The HH secreting cell releases the HH ligand, activating
    Smo and causing it to translocate to the cilium. SuFu binds with Gli2/3 and moves
    into the cilium, where Gli2/3 is phosphorylated by EVC and EVC2, causing Gli2/3
    to separate from SuFu. Gli3 remains in the cytoplasm, while Gli2 crosses the nuclear
    membrane into the nucleus, where it initiates the transcription of target genes.
    Created with BioRender.com'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMO
  - SMOX
  - GSK3A
  - GSK3B
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - SUFU
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - PRSS30P
  - PTCH1
  - GLI3
  - GLI2
  - KIF7
  - BTRC
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CDON
  - GAS1
  - REG3A
  - RPL29
  - ST13
  - HHIP
  - EVC
  - EVC2
  - GLI1
  - PTCH2
  - 'Off'
  - Protein
---
